CCSG COMPONENT 001 ? LEADERSHIP, PLANNING AND EVALUATION PROJECT SUMMARY/ABSTRACT The Vanderbilt-Ingram Cancer Center (VICC) has a dynamic and diverse leadership team that encompasses expertise across all facets of the cancer research and clinical enterprises and provides oversight of basic, clinical, translational, prevention, control and population-based research programs. Working collaboratively and effectively, the senior leaders have enhanced organizational capabilities, and planning and evaluation activities to reduce the cancer burden in our community and globally. Leadership, Planning and Evaluation activities provide a structured workstreams for assessing our current status, identifying opportunities and formulating approaches for implementing the VICC mission. VICC carries out internal and external evaluation and strategic planning to inform and support its decision-making processes. The significant accomplishments of VICC membership and leadership, described throughout this renewal application, provide evidence of an effective and productive leadership team and the use of planning and evaluation (internal and external) processes. Since the last competing renewal a new strategic plan was initiated with a focus on expansion of research programs through continued recruitment of 67 talented investigators that joined the VICC membership and collectively advanced scientific discovery. As the goals of the 2014-2019 VICC Strategic Plan have been largely accomplished, in 2017, the Director and Senior Leadership embarked upon a new strategic planning process, which has been approved for the next project period and endorsed by the External Scientific Advisory Board (ESAB). The intent of the plan is to continue to invest in programs and people that are essential for continued translation of discoveries to patients, expand select areas of research as dictated by needs and opportunities and further strengthen the position of the matrix Center within the region, nation and worldwide. Key objectives of the new plan include: 1) advancing fundamental discoveries, 2) moving discoveries to interventions, 3) enabling a systems approach to cancer, and 4) reducing cancer disparities and burden. External evaluation is provided by the ESAB, Community Advisory Board, and Board of Overseers; providing expert guidance and insights to VICC leadership and membership on opportunities for collaborations and engagement, catchment area needs, development of programs, merit of research accomplishments and feedback on performance. Several internal mechanisms provide comprehensive planning and evaluation within VICC; these include the Executive Committee, Research Program Leaders Committee, Shared Resource Oversight Group, CRCERA Advisory Committee, and others. Together, these external and internal evaluation groups provide advice to the Director, who has ultimate responsibility and authority for setting the vision and priorities for the Center as a whole in order to promote transdisciplinary scientific advances that can be translated to patients and community.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA068485-25
Application #
10024652
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1998-09-01
Project End
2025-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
25
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Saito-Diaz, Kenyi; Benchabane, Hassina; Tiwari, Ajit et al. (2018) APC Inhibits Ligand-Independent Wnt Signaling by the Clathrin Endocytic Pathway. Dev Cell 44:566-581.e8
Cardin, Dana B; Thota, Ramya; Goff, Laura W et al. (2018) A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer. Am J Clin Oncol 41:772-776
Bloodworth, Melissa H; Rusznak, Mark; Pfister, Connor C et al. (2018) Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology. J Allergy Clin Immunol 142:683-687.e12
Dutter, Brendan F; Ender, Anna; Sulikowski, Gary A et al. (2018) Rhodol-based thallium sensors for cellular imaging of potassium channel activity. Org Biomol Chem 16:5575-5579
Hormuth 2nd, David A; Weis, Jared A; Barnes, Stephanie L et al. (2018) Biophysical Modeling of In Vivo Glioma Response After Whole-Brain Radiation Therapy in a Murine Model of Brain Cancer. Int J Radiat Oncol Biol Phys 100:1270-1279
Rojas, Juan D; Lin, Fanglue; Chiang, Yun-Chen et al. (2018) Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy. Theranostics 8:141-155
Lewis Jr, James S; Shelton, Jeremy; Kuhs, Krystle Lang et al. (2018) p16 Immunohistochemistry in Oropharyngeal Squamous Cell Carcinoma Using the E6H4 Antibody Clone: A Technical Method Study for Optimal Dilution. Head Neck Pathol 12:440-447
Vierra, Nicholas C; Dickerson, Matthew T; Jordan, Kelli L et al. (2018) TALK-1 reduces delta-cell endoplasmic reticulum and cytoplasmic calcium levels limiting somatostatin secretion. Mol Metab 9:84-97
Schlegel, Cameron; Weis, Victoria G; Knowles, Byron C et al. (2018) Apical Membrane Alterations in Non-intestinal Organs in Microvillus Inclusion Disease. Dig Dis Sci 63:356-365
Piñeros, Marion; Frech, Silvina; Frazier, Lindsay et al. (2018) Advancing Reliable Data for Cancer Control in the Central America Four Region. J Glob Oncol :1-11

Showing the most recent 10 out of 2462 publications